Skip to main content
TipRanks
Go Ultimate75% OFF

Orient Europharma Co., Ltd. (4120) Balance Sheet

Orient Europharma Co., Ltd. Balance Sheet

Orient Europharma Co., Ltd.'s total assets for Q2 2026 were NT$11.75B, an increase of 1.17% from the previous quarter. TW:4120 total liabilities were NT$5.41B for the fiscal quarter, a 11.37% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 12.21BNT$ 11.57BNT$ 10.81BNT$ 10.43BNT$ 9.40B
NT$ 4.85BNT$ 5.75BNT$ 6.65BNT$ 6.99BNT$ 5.95B
NT$ 7.35BNT$ 5.82BNT$ 4.16BNT$ 3.44BNT$ 3.45B

Currency in TWD

Orient Europharma Co., Ltd. Liabilities to Assets

05B10B15B36 %48 %60 %72 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets